TrialDiabetes, obesity & metabolism2020

Efficacy and safety of dual add-on therapy with dapagliflozin plus saxagliptin versus glimepiride in patients with poorly controlled type 2 diabetes on a stable dose of metformin: Results from a 52-week, randomized, active-controlled trial.

Juan P Frias et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.